Foti D, Kaufman K D, Chazenbalk G D, Rapoport B
Thyroid Molecular Biology Unit, V.A. Medical Center, San Francisco, California 94121.
Mol Endocrinol. 1990 May;4(5):786-91. doi: 10.1210/mend-4-5-786.
Using site-directed mutagenesis, we introduced two stop codons immediately upstream of the putative transmembrane domain in human thyroid peroxidase (hTPO) cDNA, truncating the carboxyl terminus of hTPO (933 amino acids) by 85 residues. Mutated hTPO cDNA, inserted into a eukaryotic expression vector, was stably transfected into Chinese hamster ovary (CHO) cells. Immunoprecipitation of cellular 35S-methionine-labeled proteins with Hashimoto's serum revealed a 105-101 kilodalton doublet. In contrast, cells transfected with wild-type hTPO yielded a 112-105 kilodalton doublet. In pulse-chase experiments, CHO cells expressing the truncated hTPO protein secreted immunoprecipitable TPO into the culture medium after 4 h of chase, with levels accumulating progressively over a 24-h period. In contrast, CHO cells expressing wild-type hTPO released no immunoprecipitable TPO into the culture medium. The secreted, truncated form of hTPO appeared as a single band of lesser electrophoretic mobility, as opposed to the doublet expressed within cells. TPO enzymatic activity was present in conditioned media from CHO cells transfected with the mutated hTPO, but was absent in media from cells expressing wild-type hTPO. The stability of the mutated protein appeared similar to that of wild-type hTPO. In summary, we have generated a mutated, secreted form of hTPO that is enzymatically active and immunologically intact. Our data confirm the existence of a transmembrane domain in hTPO, and that hTPO is predominantly an enzyme with an extracellular orientation. The secreted form of hTPO has the potential for generating large amounts of soluble TPO protein for use in future structural and immunological studies.
我们利用定点诱变技术,在人甲状腺过氧化物酶(hTPO)cDNA推测的跨膜结构域上游紧邻位置引入两个终止密码子,使hTPO的羧基末端(933个氨基酸)截短了85个残基。将突变的hTPO cDNA插入真核表达载体后,稳定转染至中国仓鼠卵巢(CHO)细胞。用桥本氏血清对细胞内35S - 甲硫氨酸标记的蛋白质进行免疫沉淀,结果显示为一条105 - 101千道尔顿的双条带。相比之下,转染野生型hTPO的细胞产生的是一条112 - 105千道尔顿的双条带。在脉冲追踪实验中,表达截短hTPO蛋白的CHO细胞在追踪4小时后将可免疫沉淀的TPO分泌到培养基中,且在24小时内水平逐渐积累。相比之下,表达野生型hTPO的CHO细胞未向培养基中释放可免疫沉淀的TPO。分泌的截短形式的hTPO呈现为一条电泳迁移率较低的单条带,这与细胞内表达的双条带不同。突变hTPO转染的CHO细胞的条件培养基中存在TPO酶活性,而表达野生型hTPO的细胞的培养基中则没有。突变蛋白的稳定性似乎与野生型hTPO相似。总之,我们产生了一种突变的、可分泌的hTPO形式,其具有酶活性且免疫完整性良好。我们的数据证实了hTPO中存在跨膜结构域,并且hTPO主要是一种具有细胞外定位的酶。hTPO的分泌形式有潜力产生大量可溶性TPO蛋白,用于未来的结构和免疫学研究。